VEGFA and diabetes mellitus: Comparing healthy diabetics to those with cardiovascular complications revealed a reduction in EG-VEGF and TIMP-4 (in addition to LAP (TGF-b1), Leptin, PD-ECGF, and Serpin F1) in all patients with diabetes with CAD while TIMP-1 was significantly increased.